US CDC Panel Supports Moderna, Janssen COVID Vaccine Boosters But Strips Out Preference Language For Homologous Dosing

ACIP pushes back on proposed policy recommendation that the same product used for the primary regimen should be used for the booster, saying risk/benefit and other considerations necessitate more flexibility afforded by 'mix and match' approach.

Mix and match
ACIP members liked the flexibility offered by being able to mix and match a booster dose with a different primary vaccination series. • Source: Alamy

A US Centers for Disease Control and Prevention advisory committee on 21 October recommended use of COVID-19 vaccine booster doses for certain individuals originally vaccinated with Moderna, Inc.’s mRNA vaccine, and all individuals who received Janssen Biotech Inc.’s adenovirus vaccine, but backed away from expressing a preference for use of homologous boosters.

CDC director Rochelle Walensky endorsed the Advisory Committee on Immunization Practices’ favorable recommendations within hours of the meeting’s conclusion. The...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet